The occurrence of new onset hyperlipidaemia is similar in renal transplant recipients receiving either cyclosporine or tacrolimus in first 3 months post-transplant , but there is room for more research in this field as dyslipidaemia following successful renal transplantation is a frequent and persistent complication .